PATRICK W SMITH

CIK 1167028 · CHIEF EXECUTIVE OFFICER · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.35B

Companies

3

Total Filings

107

Lifetime Open-Market Net

-$680.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AXON CHIEF EXECUTIVE OFFICER 3,060,997 $441.73 $1.35B -$615.71M 43 2026-06-08
Insight Molecular Diagnostics Inc. (OCX) Delisted 10%+ Owner 2,872,671 $3.20 $9.19M $2.45M 5 2025-02-11
AXON ENTERPRISE, INC. (AAXN) Delisted CHIEF EXECUTIVE OFFICER 370,310 -$67.10M 21 2020-12-23

Recent Filings · Page 8 of 11

107 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-02-21 Grant (A) +28,173 $0
2017-02-21 Grant (A) +32,917 $872.3K
2016-03-17 Mixed −90,000 $0
2016-02-16 Grant (A) +45,462 $703.8K
2015-05-11 Mixed −160,000 -$7.92M
2015-03-05 Sell (S) −4,889 -$107.7K
2015-02-23 Grant (A) +11,046 $300.0K
2014-09-16 Mixed −115,000 -$2.74M
2014-03-14 Sell (S) −95,000 -$1.75M
2014-03-04 Mixed −49,664 -$3.38M
Showing 7180 of 107
Page 8 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.